AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.
Atricure stock last closed at $32.01, down 0.22% from the previous day, and has increased 36.5% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.47 percentage points. Atricure stock is currently +69.01% from its 52-week low of $18.94, and -25.75% from its 52-week high of $43.11.
There are currently 48.88M shares of ATRC outstanding. The market capitalization of ATRC is $1.56B. In the last 24 hours, 450,263 ATRC shares were traded.
How to Buy Atricure Stock
Not sure how to invest in Atricure stock? Here's how.
Choose where to buy Atricure stock: You need to pick an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Atricure stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Fund your brokerage account: Choose your payment method and add your info.
Evaluate Atricure stock: The Atricure ticker symbol is ATRC. Is Atricure stock a good investment? Should you buy shares of ATRC? How do ATRC's underlying business fundamentals look? Do top analysts think Atricure is a good buy? Why has ATRC's stock price moved recently? (Hint: Our stock market research tools can help you decide if ATRC is a good stock to buy).
Place your ATRC trade: Decide if you will purchase ATRC shares at the current market price or use a limit order to purchase ATRC shares at a specific price.
Watch your investment in ATRC: Create a watchlist to the latest updates on your new investment in Atricure shares.
Step 1: Choose where to buy Atricure stock
You need a brokerage account to access the NASDAQ market and buy ATRC stock.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our experience, eToro is the best stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global markets: From Tech to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal info so you are able to invest in ATRC stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Atricure stock
Once you have chosen the best place to buy Atricure stock, it's very important to evaluate their stock before you buy, so you can understand the risk and upside.
Atricure shares data
ATRC Price
$32.01
1w %
1.17%
1y %
36.5%
5y %
-19.63%
P/E
-33.69x
P/B
3.39x
P/S
3.23x
PEG
N/A
Revenue
$465.31M
Earnings
-$44.70M
Fore. Rev. Growth
12.48%
Fore. Earn. Growth
N/A
Market Cap
$1.56B
Next Earnings
Apr 29, 2025
Next Dividend
N/A
ATRC Due Diligence Score
WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.
Total ATRC debt is lower than 5 years ago, relative to shareholder equity.
There are more short-term assets than short-term liabilities on the ATRC balance sheet.
There are more short-term assets than long-term liabilities on the ATRC balance sheet.
Failed Health Checks:
ATRC earnings of -$37.27M is not sufficient to cover its interest payments.
ATRC's operating cash flow of $12.20M allows it to safely service it's debt of $76.53M.
ATRC profit margin has gone down from -7.6% to -9.6% in the past year.
Is it a good time to buy Atricure stock, according to analysts?
Out of 9 Wall Street analysts who give forecasts on ATRC, the consensus analyst rating on ATRC is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent ATRC Analyst Upgrades/Downgrades
Matthew O'Brien, a bottom 4% analyst from Piper Sandler maintains ATRC with a strong buy rating and raises their ATRC price target from $40.00 to $50.00, on Feb 13, 2025.
Rick Wise, a top 8% analyst from Stifel Nicolaus maintains ATRC with a strong buy rating and raises their ATRC price target from $36.00 to $48.00, on Feb 13, 2025.
Stifel Nicolaus's Rick Wise raised their price target on AtriCure (NASDAQ: ATRC) by 33.3% from $36 to $48 on 2025/02/13. The analyst maintained their Strong Buy rating on the stock.
AtriCure reported its Q4 and FY 2024 earnings.
Wise highlighted that management reaffirmed its (2025/01/13) initial revenue guidance of $517M to $527M.
That brackets Stifel Nicolaus' estimate, so little changed in their model, the analyst noted.
Earnings Report
AtriCure reported:
For Q4 2024:
Loss per share of $0.08, which beat the Zacks Consensus Estimate of $(0.15) and Q4 2023's $(0.21).
Revenue of $124.28M, which missed the Zacks Consensus Estimate by 0.01% but beat Q4 2023's $106.54M.
For FY 2024:
Loss per share of $0.67, up from FY 2023's $(0.75).
Revenue of $465.3M, up 16.5% Y/Y.
For FY 2025, management guided:
Loss per share of $0.57 to $0.64.
Revenue of $517M to $527M.
President & CEO Michael Carrel commented: “2024 was another outstanding year at AtriCure, marked by continued progress on driving growth, improving profitability, and the introduction of several meaningful product launches across our key franchises.
“With the breadth and performance of our business, I am optimistic for the future of AtriCure and look forward to sharing our pipeline and financial outlook at our Analyst and Investor Day in 2025/03.”
Robbie Marcus, a top 20% analyst from JP Morgan maintains ATRC with a strong buy rating and raises their ATRC price target from $30.00 to $40.00, on Oct 30, 2024.
Danielle Antalffy, a bottom 4% analyst from UBS maintains ATRC with a strong buy rating and raises their ATRC price target from $35.00 to $40.00, on Oct 30, 2024.
Last year, ATRC revenue was $465.31M. In the last five year, ATRC's revenue has grown by 15.05% per year. This was faster than the Medical Instruments & Supplies industry average of 8.99%.
No, Atricure doesn't provide an income stream by paying out dividends.
What others are saying about ATRC
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your ATRC trade
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly the easiest way to buy.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount, place a limit order.
Hit the Open Trade button and your broker will execute the order.
If you want additional help with buying stocks on eToro, watch the helpful video below:
As of Apr 17, 2025, it costs $32.01 to buy one share of Atricure stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.312 shares of ATRC.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.